Measurement Of Employment And Unemployment In India: Some Issues
This paper offers a review of the concepts and definitions used in the NSS Employment-Unemployment Surveys (EUS, for short) which have remained virtually unchanged since they were introduced in the NSS 27th Round (1972-73) based on the analysis and recommendations in the Report of the Expert Group on Unemployment Estimate – better known as the Dantwala Committee Report (GOI, 1970). It also examines critically the employment-unemployment estimates derived/derivable from EUS and the use of such estimates for planning and policy.
Labor Quality in Market Services in India
The services sector in India has been growing fast and now contributes more than half of GDP. It employs the highest percentage of the ‘educated’ manpower. The paper focuses on estimating labor quality in broad sectors of the Indian economy, especially market services during the period 1983-2011. It highlights data limitations and data challenges faced while calculating the index. It explores the drivers of labor quality growth in the market services. The components included in the index are the number of workers by education, age and gender. The results of labor quality indices show that the quality changes have been highest during the period- 2001-2011 and have been driven by educational attainment. Services have also experienced the highest growth in labor quality and it has been driven more by market services. Finally, within market services, it has been slow in transport services, and hotels & restaurants but fast in telecommunication, and financial services.
Botulinum toxin in the management of chronic migraine: clinical evidence and experience
Chronic migraine (CM) is a severely disabling neurological condition characterized by episodes of pulsating unilateral or bilateral headache. The United States Food and Drug Administration (FDA) approved onabotulinumtoxinA (Botox®) for the prophylactic treatment of CM in 2010. It has been shown that onabotulinumtoxinA is effective in the reduction of headache frequency and severity in patients with CM. Treatment is well tolerated by the patients. This review reports on the history of botulinum neurotoxin (BoNT) in CM and presents the current clinical evidence for the use of onabotulinumtoxinA in the treatment of CM.